• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

EndoChoice

Boston Scientific closes $210m EndoChoice buy

November 22, 2016 By Brad Perriello

Boston Scientific (NYSE:BSX) said today that it closed its $210 million buyout of EndoChoice (NYSE:GI) and its line of devices for treating gastrointestinal disease. The $8-per-share tender offer was originally slated to expire at midnight Nov. 4. Marlborough, Mass.-based Boston Scientific later moved the deadline out to Nov. 21. they  September. Alpharetta, Ga.-based EndoChoice took itself public in June 2015 […]

Filed Under: Endoscopic, Mergers & Acquisitions, Wall Street Beat Tagged With: Boston Scientific, EndoChoice

Boston Scientific extends $210 million tender offer for EndoChoice

November 4, 2016 By Brad Perriello

Boston Scientific (NYSE:BSX) said today that it’s extending its $210 million tender offer for EndoChoice (NYSE:GI) and its line of devices for treating gastrointestinal disease. The $8-per-share tender offer was slated to expire at midnight Nov. 4. Marlborough, Mass.-based Boston Scientific said it’s moving the deadline out to Nov. 21 “to allow additional time for the satisfaction of […]

Filed Under: Endoscopic, Mergers & Acquisitions, Wall Street Beat Tagged With: Boston Scientific, EndoChoice

Boston Scientific launches tender offer for EndoChoice

October 7, 2016 By Brad Perriello

Boston Scientific (NYSE:BSX) said today that it launched the tender offer for its pending, $210 million  acquisition of EndoChoice (NYSE:GI) and its line of devices for treating gastrointestinal disease. The $8-per-share tender offer is slated to expire at midnight Nov. 4, Marlborough, Mass.-based Boston Scientific said. EndoChoice directors, affiliated funds and other stockholders have already agreed […]

Filed Under: Endoscopic, Mergers & Acquisitions, Wall Street Beat Tagged With: Boston Scientific, EndoChoice

Boston Scientific to pay $210m for EndoChoice

September 27, 2016 By Brad Perriello

Boston Scientific (NYSE:BSX) said today that it agreed to pay $210 million for EndoChoice (NYSE:GI) and its line of devices for treating gastrointestinal disease. The $8-per-share offer is slated to close by the end of the year, the companies said. EndoChoice took itself public in June 2015 with an IPO that brought in some $96 million. “The addition […]

Filed Under: Endoscopic, Mergers & Acquisitions, Wall Street Beat Tagged With: Boston Scientific, EndoChoice

EndoChoice wins FDA 510(k) for Lumos imaging software

August 4, 2016 By Fink Densford

EndoChoice said today it won FDA 510(k) clearance for its Lumos imaging software system, part of the company’s 3 Fuse Full Spectrum Endoscopy system, and launched the system in the U.S. The Lumos system is designed with adaptive matrix imaging to analyze and selectively enhance vascularity, surface texture and color of abnormal tissue to return more […]

Filed Under: Imaging Tagged With: EndoChoice

EndoChoice wins FDA 510(k) for Orca endoscope valves, announces multi-product launches

May 23, 2016 By Fink Densford

EndoChoice said it won FDA 510(k) clearance for its Orca sterile, single-use air, water and suction valves designed for Olympus 160, 180 and 190 flexible endoscopes, and announced the launch of its 3rd-gen Fuse endoscopy system and RescueNet retrieval device. With the clearance for the Orca valves, as well as previous regulatory wins, EndoChoice will begin sales […]

Filed Under: 510(k), Endoscopic, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: EndoChoice

Medtech trio sets $297m offering terms

May 26, 2015 By Brad Perriello Leave a Comment

IPO Tuesday: Medtech trio sets offering terms

A trio of medtech companies set terms for their upcoming public offerings today, announcing plans to raise a collective $297 million.

Filed Under: Funding Roundup, Initial Public Offering (IPO), News Well Tagged With: Corindus Vascular Robotics, EndoChoice, Evolent Health

EndoChoice files for $115m IPO

May 6, 2015 By Brad Perriello Leave a Comment

EndoChoice files for $115m IPO

EndoChoice said today that it filed for an initial public offering that could fetch as much as $115 million, scarcely 2 months after pulling down a $57 million funding round for its Fuse full-spectrum endoscope.

Filed Under: Endoscopic, Initial Public Offering (IPO), News Well Tagged With: EndoChoice

HART CEO Green bows out | Personnel Moves

April 21, 2015 By Brad Perriello Leave a Comment

HART CEO Green bows out | Personnel Moves

Filed Under: News Well Tagged With: EndoChoice, Harvard Apparatus Regenerative Technology (HART), IlluminOss Medical Inc., Merit Medical Systems, Nephros, Nonin Medical Inc., Nu-Med Plus, OMNIlife Science Inc., Personnel Moves, VisionCare Ophthalmic Technologies, Volcano Corp.

Tandem Diabetes plans $60m offering | Medtech funding for the week of March 2, 2015

March 6, 2015 By MassDevice

Diabetes: Tandem plans $60m offering

March 2, 2015 by Mark Hollmer

Filed Under: Diabetes, Funding Roundup, News Well Tagged With: Deerfield Management, EndoChoice, InspireMD, Orthosensor Inc., tandemdiabetes

EndoChoice raises $57m for Fuse endoscope

March 5, 2015 By Brad Perriello Leave a Comment

EndoChoice raises $57m for Fuse endoscope

EndoChoice today said it raised $57 million for its Fuse full-spectrum endoscope from a group that included prior backers and new investors.

Filed Under: Endoscopic, Funding Roundup, News Well Tagged With: Deerfield Management, EndoChoice

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS